Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study.

Neurology
Gina M PelosoSudha Seshadri

Abstract

To determine the joint role of ideal cardiovascular health (CVH) and genetic risk on risk of dementia. We categorized CVH on the basis of the American Heart Association Ideal CVH Index and genetic risk through a genetic risk score (GRS) of common genetic variants and the APOE ε4 genotype in 1,211 Framingham Heart Study (FHS) offspring cohort participants. We used multivariable Cox proportional hazards regression models to examine the association between CVH, genetic risk, and incident all-cause dementia with up to 10 years of follow-up (mean 8.4 years, 96 incident dementia cases), adjusting for age, sex, and education. We observed that a high GRS (>80th percentile) was associated with a 2.6-fold risk of dementia (95% confidence interval [CI] of hazard ratio [HR] 1.23-5.29; p = 0.012) compared with having a low GRS (<20th percentile); carrying at least 1 APOE ε4 allele was associated with a 2.3-fold risk of dementia compared with not carrying an APOE ε4 allele (95% CI of HR 1.49-3.53; p = 0.0002), and having a favorable CVH showed a 0.45-fold lower risk of dementia (95% CI of HR 0.20-1.01; p = 0.0527) compared to having an unfavorable CVH when all 3 components were included in the model. We did not observe an interaction between...Continue Reading

References

Sep 1, 1979·American Journal of Epidemiology·W B KannelW P Castelli
Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jan 1, 1995·Revue neurologique·C Berr
Jul 15, 1999·JAMA : the Journal of the American Medical Association·M N HaanL Kuller
Dec 3, 1999·BMJ : British Medical Journal·D G Altman, P K Andersen
May 22, 1963·Annals of the New York Academy of Sciences·T R DAWBERL P LYELL
Dec 30, 2006·PLoS Genetics·Nick PattersonDavid Reich
Jul 17, 2009·The New England Journal of Medicine·Rosalie A Kane, Robert L Kane
Jan 22, 2010·Circulation·Donald M Lloyd-JonesUNKNOWN American Heart Association Strategic Planning Task Force and Statistics Committee
Jan 25, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Sudha SeshadriHelena C Chui
Feb 19, 2011·Journal of Cardiovascular Medicine·Ralph L Sacco
Oct 6, 2011·Journal of Alzheimer's Disease : JAD·Eric M ReimanPierre N Tariot
Apr 5, 2012·Current Alzheimer Research·Rhoda AuAnn C McKee
Oct 23, 2015·Brain : a Journal of Neurology·Valentina Escott-PriceJulie Williams
Feb 11, 2016·The New England Journal of Medicine·Claudia L SatizabalSudha Seshadri
Apr 14, 2016·Stroke; a Journal of Cerebral Circulation·Matthew P PaseSudha Seshadri
Jun 25, 2016·Journal of Alzheimer's Disease : JAD·Vincent ChourakiUNKNOWN International Genomics of Alzheimer’s Project
Jul 25, 2017·Lancet·Gill LivingstonNaaheed Mukadam
Aug 11, 2017·Neurology·Yen Ying LimUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Aug 25, 2018·JAMA : the Journal of the American Medical Association·Cécilia SamieriJean-Philippe Empana
Jul 16, 2019·JAMA : the Journal of the American Medical Association·Ilianna LouridaDavid J Llewellyn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.